Prenosis

Prenosis

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://prenosis.com

Last Round

Grant

Jan 29, 2026

Total Funding Raised

$55.85M

Momentum Score

75 /100

Company Overview

Prenosis is a healthcare technology company that develops integrated diagnostics and therapeutics for critical care conditions using artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Precision Medicine, Healthcare Analytics, Medical Devices

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

sepsis diagnosisAI diagnosticsoftware as a medical deviceSaMDFDA-authorized AIsepsis risk predictionFDA cleared AIprecision medicineclinical decision supportEHR integrationclinical AIpredictive diagnosticsacute care AIproprietary biobankclinical trial networkgovernment contracts

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prenosis Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Prenosis Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJan 29, 2026
Series AJan 29, 2024
GrantJul 12, 2023
GrantJun 7, 2023
Early FundingMar 9, 2022
Grant
Nov 17, 2021

Key People

Founding team and executive leadership

Bobby Reddy

CEO Co-Founder

Founding Team

Angela Thomas

Chief Financial Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 29, 2026

    $20M raised in grant funding.

  • Dec 19, 2025

    Received the inaugural UL Enterprise Safety Science Award for Sepsis ImmunoScore.

Prenosis Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Prenosis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Prenosis's valuation, stock price, and market status.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range49
Year Founded2014
Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.